跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE - HSA Drug Approval Details
Approvals
/
HSA
/
INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE
Approved
STANDARD
INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
af406148f1af5e9e
Company
Unknown
Type
Standard
Approval Details
Approval Id
af406148f1af5e9e
Drug Name
INCRUSE ELLIPTA INHALATION POWDER 62.5 MCG/DOSE
Active Ingredients
Umeclidinium Bromide 74.2 mcg (micronised) eqv. Umeclidinium
62.5 mcg/dose
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
af406148f1af5e9e
Type
Standard
Back to HSA Approvals
